Due mainly to policy uncertainty, global renewable energy spending fell 12.4% in 2012 to $244.4 billion, according to a report compiled by the Frankfurt School, UN Environment Programme and Bloomberg New Energy Finance. Developed countries’ spending fell 29% to $132 billion, but developing countries’ spending rose 19% to a record $112 billion. China’s spending grew […]
Fears over higher US interest rates and a reduction in the Federal Reserve’s quantitative easing measures sent equity markets lower in June. Ironically, markets erased some of the earlier losses as first quarter US GDP was revised down to 1.8% growth from 2.4%. The weaker-than-expected economic growth appeased investors’ concerns that the Federal Reserve’s bond […]
R&D spending by drug firms 2012–2018 will have a compound annual growth rate (CAGR) of 1.4% to $149.4 billion, compared to 6.6% for 2004–2011. Pharmaceutical R&D spending fell 0.3% in 2012 to $137.4 billion and should fall 1.5% this year but grow 1.6% in 2014. Novartis is expected to maintain its position from 2012 to […]
Calgary, Canada 6/28/13; Toronto, Canada 6/28/13—Galvanic Applied Sciences has received an acquisition offer from a group of private equity firms, led by Tuckerman Capital. Listed on the Toronto stock exchange, Galvanic is a provider of instrumentation for the natural gas processing and distribution markets and for the liquids process markets. Tuckerman is offering CAD 1.70 […]
East Grinstead, UK 6/27/13—Publicly listed UK scientific instrument firm Judges Scientific has acquired Scientifica for £12.0 million ($18.6 million = £0.65 = $1) in cash and a maximum earn out of £1 million ($2 million). Scientifica designs, manufactures and sells systems for electrophysiology research, including micromanipulators, optical microscopes and associated mounting solutions. The company also […]
Auburn, WA 6/20/13; Tacoma, Washington 6/18/13—Syntrix Biosystems has announced a final judgment of $115 million in its 2010 patent infringement case against Illumina in the US District Court for the Western District of Washington (see IBO 4/30/11). In March, a jury found Illumina guilty of infringing US Patent No. 6,951,682 covering synthetic matrix and array […]
Seattle, WA 6/25/13; Washington, DC 6/25/13—NanoString Technology shares debuted on the NASDAQ Global Market under the symbol NSTG on June 26 (see IBO 5/31/13). The company listed 5.4 million shares at a price of $10 per share. NanoString expects to raise net proceeds of $46.9 million. The company also granted underwriters a 30-day option to […]
Large, publicly held testing, inspection and certification companies recorded solid growth last year but also continued to restructure operations. Two of the largest such companies are Intertek and SGS, which share a long history in the testing services business and diversified offerings serving a wide range of industries. Intertek, a provider of testing, outsourcing, certification, […]
Productivity growth for 10 of 17 major publicly held analytical instrument and lab product companies (see table, page 6) declined in fiscal 2012 (FY12) due to expansion in emerging markets and acquisitions. On a currency-neutral basis, the average sales-per-employee ratio for the 17 companies fell 0.4% to $293,902 in FY12. In spite of stable sales […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
